These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23737589)

  • 41. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histopathology of brow fat in thyroid-associated orbitopathy.
    Hwang CJ; Khadavi NM; Papageorgiou K; Said J; Chong K; Lee D; Smith TJ; Goldberg RA; Douglas RS
    Ophthalmic Plast Reconstr Surg; 2012; 28(1):27-9. PubMed ID: 22082595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glabellar rhytids in thyroid-associated orbitopathy.
    Saks ND; Burnstine MA; Putterman AM
    Ophthalmic Plast Reconstr Surg; 2001 Mar; 17(2):91-5. PubMed ID: 11281597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transorbital decompression. Indications and results.
    Linberg JV; Anderson RL
    Arch Ophthalmol; 1981 Jan; 99(1):113-9. PubMed ID: 6893928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report.
    Salvi M; Vannucchi G; Sbrozzi F; Del Castello AB; Carnevali A; Fargion S; Beck-Peccoz P
    Thyroid; 2004 Aug; 14(8):631-4. PubMed ID: 15320978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
    Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
    Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N
    Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The initial clinical characteristics of Graves' orbitopathy vary with age and sex.
    Kendler DL; Lippa J; Rootman J
    Arch Ophthalmol; 1993 Feb; 111(2):197-201. PubMed ID: 8431156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid eye disease.
    Scott IU; Siatkowski MR
    Semin Ophthalmol; 1999 Jun; 14(2):52-61. PubMed ID: 10758212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid-associated orbitopathy.
    Alsuhaibani AH; Nerad JA
    Semin Plast Surg; 2007 Feb; 21(1):65-73. PubMed ID: 20567660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyroid-associated orbitopathy in patients with Hashimoto's thyroiditis: a case report.
    Grzesiuk W; Szydlarska D; Pragacz A; Bar-Andziak E
    Pol Arch Med Wewn; 2008 May; 118(5):318-21. PubMed ID: 18619184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid eye disease: review and case reports.
    McGarvey EJ
    J Am Optom Assoc; 1990 Sep; 61(9):689-700. PubMed ID: 2212462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical manifestations and treatment outcome of optic neuropathy in thyroid-related orbitopathy.
    Ben Simon GJ; Syed HM; Syed H; Douglas R; Schwartz R; Goldberg RA; McCann JD
    Ophthalmic Surg Lasers Imaging; 2006; 37(4):284-90. PubMed ID: 16898388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronal or swinging eyelid decompression for patients with disfiguring proptosis in Graves' orbitopathy? Comparison of results in one center.
    Sasim IV; de Graaf ME; Berendschot TT; Kalmann R; van Isterdael C; Mourits MP
    Ophthalmology; 2005 Jul; 112(7):1310-5. PubMed ID: 15950284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the retrobulbar space in Graves' orbitopathy using color Doppler ultrasonography].
    Cmelo J; Chynoranský M; Zvác J; Rybár M
    Cesk Slov Oftalmol; 1997 May; 53(2):106-11. PubMed ID: 9296857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anterior ischemic optic neuropathy in Graves' disease.
    Dosso A; Safran AB; Sunaric G; Burger A
    J Neuroophthalmol; 1994 Sep; 14(3):170-4. PubMed ID: 7804422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transorbital approach to decompression in Graves' disease.
    Anderson RL; Linberg JV
    Arch Ophthalmol; 1981 Jan; 99(1):120-4. PubMed ID: 6893929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
    Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
    Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Graves' disease presenting with bilateral acute painful proptosis, ptosis, ophthalmoplegia, and visual loss.
    Leonard TJ; Graham EM; Stanford MR; Sanders MD
    Lancet; 1984 Aug; 2(8400):431-3. PubMed ID: 6147503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute orbital edema causing reversible blindness after the administration of intravenous contrast agent in a patient with thyroid eye disease.
    Fry EL; Fante RG
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):330-1. PubMed ID: 18645451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.